Latest News and Press Releases

BRIDGEWATER, N.J., April 01, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...

ZUG, Switzerland and CAMBRIDGE, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...

CHARLESTON, S.C., April 01, 2019 (GLOBE NEWSWIRE) -- Benefitfocus, Inc. (NASDAQ: BNFT), a leading cloud-based benefits management platform and services provider, today announced that the...

Highlights Interpretation of the conventional and BMR wireline log data indicates: Interval between 404 and 464 metres has approximately 18 metres of net coal with 12 metres of that being bright...

Fairfax VA, April 01, 2019 (GLOBE NEWSWIRE) -- Visium Technologies, Inc. (OTCPink: VISM) (“Visium” or the “Company”) announced today that it has entered into a technology license agreement with The...

MONTREAL, April 01, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that top-line results, from a study funded by the National Institutes of Health led...

OTTAWA, April 01, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V: TBP) (OTCQB: TBPMF), today announced that the Company has renewed its CEO Guy Chamberland’s...

CAMBRIDGE, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...

WOBURN, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, today...

UTRECHT, Netherlands, April 01, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage immuno-oncology company developing Biclonics®, innovative...